Generated by AI
Biomerica Inc. is a biomedical technology company focused on developing, patenting, manufacturing, and marketing advanced diagnostic and therapeutic products. The company’s portfolio centers on in-vitro diagnostic solutions used in point-of-care settings, physicians’ offices, and hospital and clinical laboratories. Its products address a range of medical conditions, with emphasis on gastrointestinal and inflammatory diseases, food intolerances, diabetes, and other diagnostic applications. Biomerica Inc. also serves clinical laboratory, physician office, home testing, and over-the-counter channels, supporting early detection and treatment decisions across multiple healthcare environments. Based in Irvine, California, the company operates as a specialized healthcare provider with a market presence in both diagnostic testing and therapeutic product development.
Website17571 Von Karman Avenue
Irvine, CA, 92614
United States
The latest articles about BMRA.
Biomerica (BMRA) filed a registration statement Friday with the US Securities and Exchange Commissio
Summary of Aug 27's posts. Generated by AI.
Summary of Sep 4's posts. Generated by AI.
Summary of Aug 27's posts. Generated by AI.
Investors talking about BMRA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.